Our results unequivocally established that P-Rex1 is dispensable for Erk activation by stimulation of tyrosine-kinase receptors or GPCRs in breast cancer cells, and accordingly it is not implicated in mitogenic signaling. Here, PREX1 is linked to breast carcinoma.